Intercept Pharmaceuticals (ICPT) Stock Analysis 1/13/14 January 13, 2014

Intercept Pharmaceuticals (ICPT) Stock Analysis 1/13/14 January 13, 2014 -

 Follow @stockstobuy 

Intercept Pharmaceuticals (ICPT) surged again on Friday after the company reported strong liver disease drug data last week.  ICPT stock is now one of the Top Stocks in 2014 with a gain of over 550%.

Intercept Pharmaceuticals (ICPT) dropped into the close on Friday and again in after hours trading.  Shares closed the regular session at $446 and closed after hours at $418.50.  ICPT will have support at $387 as well as $373.  A break below $373 could set up a move to $340-$350 but then produce a bounce.  We will be watching it in the Stock Picks Group.

Also see - Top Stocks 2014 - Top Stock Gainers 2014

Intercept Pharmaceuticals (ICPT) Price Target - $872 by Bank of America

Intercept Pharmaceuticals (ICPT) 2014 Price Target - $872 by Bank of America -

 Follow @stockstobuy 

Intercept Pharmaceuticals (ICPT) stopped a drug trial early recently and the stock is on fire.  This morning, ICPT received multiple price target upgrades and Bank of America believe shares could eventually hit $872 - http://www.stockstobuy.org/forum/topics/intercept-pharmaceuticals-icpt-top-stocks-in-2014

Intercept Pharmaceuticals (ICPT) is now one of the top stocks in 2014 and will be volatile for months to come.  We will be watching it in the Stock Picks Group.

Also see - Top Stocks 2014 - Top Stock Gainers 2014